Stock listing

Gh Research Plc

Selected listing: 1KA · FWB · EUR · DE

Gh Research Plc (Frankfurt:1KA), Health Technology. Latest release Jun 4, 2026: GH Research Announces Publication of Phase 2a Postpartum Depression Results.

1KA:FWBEURDEUpdated October 2, 2026

Ticker: Frankfurt:1KA
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Frankfurt
Currency: EUR

Latest news from Gh Research Plc

GH Research Announces Publication of Phase 2a Postpartum Depression Results

June 3, 2026

GH Research Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026

GH Research Announces Pricing of $117.5 Million Underwritten Offering

April 29, 2026

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

April 20, 2026

GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD

March 24, 2026

All Gh Research Plc news →

Research Gh Research Plc

Gh Research Plc company profile

View the public company page for Gh Research Plc on 6ix.

Gh Research Plc news

Read company news and market updates connected to Gh Research Plc.

Gh Research Plc investor events

Find investor webinars, events, and replay context for Gh Research Plc.